Hypertrophic cardiomyopathy is an uncommon disorder of cardiac muscle typically on a genetic basis; however, the relationship of specific genotypes to clinical presentation is complex and still poorly characterized. Hypertrophic cardiomyopathy can be associated with outflow track obstruction, heart failure, and arrhythmias – it thus presents an important diagnostic and therapeutic challenge to the managing physicians. The physiology is complex, but has major implications for the patient’s lifestyle, ability to tolerate surgery, and life expectancy.

Note: This course is eligible for ACPE credit.

• To describe the hemodynamic abnormalities that can occur with the various forms of hypertrophic cardiomyopathy.
• To enumerate medications that are specifically indicated, and those that are specifically contra-indicated, in the various forms of hypertrophic cardiomyopathy.
• To define patient subsets who that might be appropriate for alcohol septal ablation, surgical myomectomy, or placement of an automatic implantable cardioverter defibrillator (AICD).